amdinocillin has been researched along with cefixime in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aberrane, S; Bechet, S; Beraud, L; Bidet, P; Birgy, A; Bonacorsi, S; Cohen, R; Cointe, A; Cuzon, G; Desmarest, M; Dommergues, MA; Ferroni, A; Gajdos, V; Haas, H; Hobson, CA; Jung, C; Launay, E; Levy, C; Madhi, F; Pinquier, D; Sobral, E; Vuthien, H | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
2 other study(ies) available for amdinocillin and cefixime
| Article | Year |
|---|---|
Clavulanate combinations with mecillinam, cefixime or cefpodoxime against ESBL-producing Enterobacterales frequently associated with blaOXA-1 in a paediatric population with febrile urinary tract infections.
Topics: Amdinocillin; Anti-Bacterial Agents; Cefixime; Cefpodoxime; Ceftizoxime; Child; Clavulanic Acid; Humans; Urinary Tract Infections | 2021 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |